Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) PT at $27.64

Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have received a consensus rating of “Buy” from the eleven analysts that are currently covering the stock, Marketbeat reports. Eleven research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have covered the stock in the […]

Leave a Reply

Your email address will not be published.

Previous post Blake Borgeson Sells 11,447 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
Next post NBC Securities Inc. Acquires New Position in Invesco Food & Beverage ETF (NYSEARCA:PBJ)